Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Thallion Enrolls First Patient in TLN-4601 Phase II Trial
PR-Canada
Sunday, September 28, 2008 - 11:58am
tags:
China Biotech in Review: Deals, Developments and Financials
Seeking Alpha
Sunday, September 28, 2008 - 11:56am
tags:
Indevus: Making Big Gains with Approval for Its New Drug
Seeking Alpha
Sunday, September 28, 2008 - 11:55am
tags:
Breckenridge Pharmaceutical Signs Letter of Intent with IDL
PR-USA
Sunday, September 28, 2008 - 11:50am
tags:
Information About the Drug Spiriva Being Linked to Increased Risk of Strokes, Heart Attacks and Cardiovascular Deaths
PR Web
Sunday, September 28, 2008 - 11:49am
tags:
J&J Gets Proactive About Bad News
Forbes
Saturday, September 27, 2008 - 12:29pm
tags:
NPS shares fall as Glaxo pulls out of drug study
Yahoo/AP
Saturday, September 27, 2008 - 12:28pm
tags:
Savient shares fall as it still seeks partner
Yahoo/AP
Saturday, September 27, 2008 - 12:27pm
tags:
Lupin`s sales to grow at 17% CAGR over next 2 yrs
MyIris, India
Saturday, September 27, 2008 - 12:23pm
tags:
FDA label doesn't quash drug suit (in CA), court says
San Francisco Gate, CA
Saturday, September 27, 2008 - 12:19pm
tags:
Roche moves HC against Cipla's copycat drug
MSN News
Saturday, September 27, 2008 - 12:17pm
tags:
Keeping balance in mind at Boehringer
Danbury News Times, CT
Saturday, September 27, 2008 - 12:16pm
tags:
Zypadhera(TM) Receives Positive Opinion from the European Committee for Medicinal Products for Human Use (CHMP) for Maintenance Treatment of Schizophrenia
CNW Telbec, Canada
Saturday, September 27, 2008 - 12:15pm
tags:
Abraham & Abraham Attorneys and Counselors at Law, LLC Announces Investigation of Securities Claims Against Medicis Pharmaceutical Corp.
Street Insider
Saturday, September 27, 2008 - 12:06pm
tags:
Concert Pharmaceuticals initiates Phase I hot flashes trial
Pharmaceutical Business Review
Saturday, September 27, 2008 - 12:05pm
tags:
J&J, Lilly Cited by U.S. Over Promotional Materials
Bloomberg
Saturday, September 27, 2008 - 12:04pm
tags:
Has the Economic Mess Diluted Biotech's Hand?
TMCnet
Saturday, September 27, 2008 - 12:03pm
tags:
AstraZeneca sees developed markets stalling
International Herald Tribune
Saturday, September 27, 2008 - 12:01pm
tags:
FDA Continues to Review Prasugrel New Drug Application
Red Orbit
Saturday, September 27, 2008 - 12:00pm
tags:
Indevus Pharmaceutical shares double as FDA deal clears path, company adds deal with Teva
Canadian Business, Canada
Saturday, September 27, 2008 - 11:56am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.